Yongtonel Tablet 35 mg (Risedronate Sodium)

Adult dose

Adults: Administer 35 mg of risedronate sodium orally once weekly. Elderly patients: No dosage adjustment is necessary in elderly patients (over 60 years of age), as the bioavailability and pharmacodynamics of this drug are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. Food interferes with the absorption of this drug. For adequate absorption, take it at least 30 minutes before breakfast, or at least 2 hours before or after food or beverages at any time of day. To facilitate passage of this drug into the stomach and reduce the possibility of esophageal irritation, take it while sitting or standing upright with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may decrease absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take a dose on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

Children under 18 years of age: Safety and efficacy have not been established.

This medication can irritate the mucosa of the stomach and esophagus, so caution is advised for patients with existing esophageal diseases, gastritis, duodenitis, ulcers, etc. It should be taken with a sufficient amount of water, and not lying down for a certain period after taking the medication can reduce esophageal irritation. If symptoms such as esophageal pain, difficulty swallowing, or chest pain occur, the medication should be stopped immediately, and a doctor should be consulted. This medication should not be used by patients with specific esophageal diseases, hypocalcemia, severe renal dysfunction, and women who are pregnant or breastfeeding. Additionally, patients with genetic issues such as lactose intolerance should not take this medication. This drug contains yellow dye, so patients allergic to this component should be cautious. Side effects such as indigestion, abdominal pain, headache, joint pain, muscle pain, rash, etc., may occur, and serious side effects such as gastrointestinal bleeding or esophageal perforation have also been reported rarely. Long-term use can rarely result in serious skeletal side effects, such as femoral fractures or osteonecrosis of the jaw, so regular medical evaluation is necessary. Taking this medication with multi-cation medications or foods containing calcium, magnesium, iron, etc., can interfere with its absorption, so dosing times should be adjusted. If pregnant or breastfeeding, this medication should be avoided or consultation with a specialist is recommended, and its safety and efficacy in children under 18 years have not been established. In case of overdose, serum calcium and phosphorus levels may decrease, requiring appropriate treatment, and in emergencies, gastric lavage or calcium supplementation may be performed. This medication should be stored out of reach of children, and transferring it to another container can compromise its quality, so caution is required.

Upper gastrointestinal mucosal irritation, bleeding, esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, infection, lower back pain, accidental injury, pain, abdominal pain, flu-like symptoms, headache, fatigue, neck pain, chest pain, allergic reaction, hypertension, constipation, diarrhea, dyspepsia, nausea, peripheral edema, arthralgia, arthritis, fracture, joint abnormality, myalgia, bone pain, dizziness, depression, insomnia, bronchitis, sinusitis, rhinitis, pharyngitis, increased cough, rash, cataract, urinary tract infection, vomiting, uveitis, scleritis, iritis, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, angioedema, blisters, skin reactions, external auditory canal osteonecrosis, jaw osteonecrosis, liver dysfunction, jaundice, anorexia, asthenia, heartburn, epigastric pain, chest discomfort, palpitations, increased sweating, facial flushing, burning sensation, kidney stones, belching, hematuria, fever, ocular pain

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to store the medication at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness and safety of the medication.

Appearance

Pale orange oval film-coated tablet

Package unit

4 tablets/PTP((4 tablets/PTP)x1)